Benefits
Lipase and α-Amylase Inhibition (Fat and Carb Blocking)
ID-alG™ inhibits two main digestive enzymes — pancreatic lipase (fat digestion) and α-amylase (starch digestion). Reduces absorption of dietary fats and carbohydrates. >50% enzyme inhibition guaranteed. Foundational mechanism.
Weight Loss with Body Composition Improvement
Nexira clinical study showed significant weight loss correlated with fat mass reduction; decreased abdominal and visceral fat; significant reduction in carb assimilation and HbA1c (glycated hemoglobin). Established in target demographic.
HbA1c Reduction
Reduction in glycated hemoglobin reflects improved long-term glucose control. Mechanism: reduced carbohydrate absorption from α-amylase inhibition + reduced glucose excursions over time. Modest but meaningful for metabolic health.
Body Shape Improvement
Reduction of abdominal and visceral fat — visible body shape improvement beyond just weight loss. Particularly relevant for older women's body composition concerns.
User Satisfaction Validation
Nexira survey: 76% convinced of weight management effect; 72% would continue using ID-alG™. High user satisfaction reflects perceived efficacy and tolerability.
Mechanism of action
Phlorotannin Enzyme Inhibition
Phlorotannins (marine polyphenols specific to brown algae; structurally similar to terrestrial tannins but distinct chemistry) inhibit pancreatic lipase and α-amylase via enzyme-substrate competitive inhibition. Reduces digestion/absorption of fats and starches.
Reduced Caloric Intake from Macronutrient Blocking
Lipase inhibition reduces fat absorption; α-amylase inhibition reduces starch absorption. Net caloric reduction supports weight management. Same mechanism category as orlistat (pharmaceutical lipase inhibitor) but weaker effect with better tolerability.
Soluble Fiber Component
Ascophyllum nodosum also provides soluble fiber (alginates, fucoidan) — additional satiety and microbiome effects.
Iodine Content Consideration
Brown seaweeds naturally contain iodine; concentrated extracts have variable iodine content — Nexira processes for safe iodine levels in supplemental form. Verify product specifications.
Clinical trials
RCT of ID-alG™ on weight, body composition, and metabolic markers.
Adults with weight management concerns (women 45+ target).
Significant weight loss correlated with fat mass; decreased fat assimilation, body fat mass, abdominal/visceral fat; reduced carb assimilation and HbA1c; body shape improvement; no signs of discomfort.
Multiple studies of brown algae phlorotannins on enzyme inhibition and metabolic effects.
In vitro and clinical.
Established phlorotannin-mediated lipase and α-amylase inhibition; modest clinical metabolic effects. Foundation for evidence-based marine algae weight management applications.